BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

This publication has 39 references indexed in Scilit:

• Chromosome Instability and Defective Recombinational Repair in Knockout Mutants of the Five Rad51 Paralogs
  Molecular and Cellular Biology, 2001
• Role of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein
  Published by Elsevier ,2001
• JAK-STAT signaling activated by Abl oncogenes
  Oncogene, 2000
• The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity
  The Journal of Experimental Medicine, 1999
• Chronic Myeloid Leukemia
  New England Journal of Medicine, 1999
• In Vitroandin VivoPotentiation of Radiosensitivity of Malignant Gliomas by Antisense Inhibition of the RAD51 Gene
  Biochemical and Biophysical Research Communications, 1998
• Regulation of Rad51 Function by c-Abl in Response to DNA Damage
  Journal of Biological Chemistry, 1998
• Role of oncogenes in resistance and killing by cancer therapeutic agents
  Current Opinion in Oncology, 1997
• Homologous recombination and the roles of double-strand breaks
  Trends in Biochemical Sciences, 1995
• Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
  Cell, 1986